1. Rockwell WJ, Ellinwood EH, Trader DW. Psychotropic drugs promoting weight gain: health risk and treatment implications. South Med J. 1983;76:1407-12.
2. Walsh AE, Smith KA, Oldman AD, et al. m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology (Berl). 1994;116:120-2.
3. Garattini S, Mennini T, Samain R. Reduction of food intake by manipulation of central serotonin: current experimental results. Br J Psychiatry. 1989;155(suppl 8):41-51.
4. Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C receptors. Nature. 1995;374:542-6.
5. Howarth PH, Emanuel MB, Holgate ST. Astemizole, a potent histamine H1 receptor antagonist: effect on allergic rhinoconjunctivitis, on antigen and histamine-induced skin response and relationship to serum levels. Br J Clin Pharmacol. 1984;18:1-8.
6. Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: a comparison of weight gain liabilities. J Clin Psychiatry. 1999;60:358-63.
7. Casey DE, Zorn S. The pharmacology of weight gain with antipsychotics. J Clin Psychiatry. 2001;62 (suppl 7):4-10.
8. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999;156:1686-96.
9. Leibowitz SF. Neurochemical system of the hypothalamus control of eating and drinking and behavior and water-electrolyte excretion. In: Morgan P, Panksepp J (eds). Handbook of the hypothalamus (vol, 3). New York: Marcel Dekker, Inc., 1980;299-438.
10. Basson BR, Kinon BJ, Taylor CC, et al. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry. 2001;62(4):231-8.
11. O’Keefe C, et al. Reversal of weight gain associated with antipsychotic treatment (paper presentation). New Orleans: American Psychiatric Association annual meeting, 2001.
12. Ball MP, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatr Serv. 2001;52(7):967-9.
13. Knox JM. A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry. 1980;136:287-9.
14. Cohen S, Glazewski R, Khan S, Khan A. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction. J Clin Psychiatry. 2001;62(2):114-16.
15. Littrell KH, et al. Educational interventions for the management of antipsychotic-related weight gain (paper presentation). New Orleans: American Psychiatric Association annual meeting, 2001.
16. Nguyen CT, Ortiz T, Franklin D, Yu B, Maguire GA. Nutritional education in minimizing weight gain associated with antipsychotic therapy. New Orleans: American Psychiatric Association annual meeting, 2001.
17. Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry. 2001;62(2):92-100.
18. Ketter TA, et al. Int J Neuropsychopharmacol. 2000;3(suppl l):S344.-
19. Floris M, Lejeune J, Deberdt W. Effect of amantadine on weight gain during olanzapine treatment. Eur Neuropsychopharmacol. 2001;11(2):181-2.
